Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sung-Wan Chun

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Diabetes, Obesity & Metabolism|August 14, 2025
Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third-line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP-4 inhibitors: A multicentre, phase 4 randomized controlled trialYun Kyung Cho, Jae-Hyoung Cho, Sang-Mo Hong, et al.
Clinical Endocrinology|April 24, 2017
Urine clusterin/apolipoprotein J is linked to tubular damage and renal outcomes in patients with type 2 diabetes mellitusSang Soo Kim, Sang Heon Song, Jong Ho Kim, et al.
Diabetes|December 29, 2007
A polymorphism in the zinc transporter gene SLC30A8 confers resistance against posttransplantation diabetes mellitus in renal allograft recipientsEun Seok Kang, Myoung Soo Kim, Yu Seun Kim, et al.
The Korean Journal of Internal Medicine|December 28, 2012
DNA methylation of RUNX3 in papillary thyroid cancerHee Ja Ko, Bo Yeon Kim, Chan Hee Jung, et al.
Journal of Atherosclerosis and Thrombosis|May 11, 2025
Comparative Effectiveness and Safety of Moderate-Intensity Pravastatin Versus Atorvastatin in Patients with Dyslipidemia: A Retrospective Cohort Study Using a Common Data Model of Multicenter Electronic Health Records in South KoreaSung Wan Chun, Hae Jin Kim, Ji A Seo, et al.
Diabetes, Obesity & Metabolism|May 15, 2020
Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeksSin Gon Kim, Kyoung Jin Kim, Kun Ho Yoon, et al.
The Journal of Clinical Endocrinology and Metabolism|September 5, 2025
Clinical Utility of Salivary Steroid Profiling for the Differential Diagnosis of Adrenal DiseasesKyoung Yeun Jung, Soyeon Park, Chaelin Lee, et al.
Diabetes, Obesity & Metabolism|December 19, 2025
Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double-blind, multicentre, therapeutic confirmatory phase 3 clinical trialSeung-Hwan Lee, Kyung Ah Han, Eun-Gyoung Hong, et al.
Endocrinology and Metabolism (Seoul, Korea)|October 22, 2021
Metabolic Subtyping of Adrenal Tumors: Prospective Multi-Center Cohort Study in KoreaEu Jeong Ku, Chaelin Lee, Jaeyoon Shim, et al.
Diabetes & Metabolism Journal|March 7, 2022
A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes MellitusBo-Yeon Kim, Hyuk-Sang Kwon, Suk Kyeong Kim, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Diabetes, Obesity & Metabolism|August 14, 2025
Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third-line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP-4 inhibitors: A multicentre, phase 4 randomized controlled trialYun Kyung Cho, Jae-Hyoung Cho, Sang-Mo Hong, et al.
Clinical Endocrinology|April 24, 2017
Urine clusterin/apolipoprotein J is linked to tubular damage and renal outcomes in patients with type 2 diabetes mellitusSang Soo Kim, Sang Heon Song, Jong Ho Kim, et al.
Diabetes|December 29, 2007
A polymorphism in the zinc transporter gene SLC30A8 confers resistance against posttransplantation diabetes mellitus in renal allograft recipientsEun Seok Kang, Myoung Soo Kim, Yu Seun Kim, et al.
The Korean Journal of Internal Medicine|December 28, 2012
DNA methylation of RUNX3 in papillary thyroid cancerHee Ja Ko, Bo Yeon Kim, Chan Hee Jung, et al.
Journal of Atherosclerosis and Thrombosis|May 11, 2025
Comparative Effectiveness and Safety of Moderate-Intensity Pravastatin Versus Atorvastatin in Patients with Dyslipidemia: A Retrospective Cohort Study Using a Common Data Model of Multicenter Electronic Health Records in South KoreaSung Wan Chun, Hae Jin Kim, Ji A Seo, et al.
Diabetes, Obesity & Metabolism|May 15, 2020
Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeksSin Gon Kim, Kyoung Jin Kim, Kun Ho Yoon, et al.
The Journal of Clinical Endocrinology and Metabolism|September 5, 2025
Clinical Utility of Salivary Steroid Profiling for the Differential Diagnosis of Adrenal DiseasesKyoung Yeun Jung, Soyeon Park, Chaelin Lee, et al.
Diabetes, Obesity & Metabolism|December 19, 2025
Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double-blind, multicentre, therapeutic confirmatory phase 3 clinical trialSeung-Hwan Lee, Kyung Ah Han, Eun-Gyoung Hong, et al.
Endocrinology and Metabolism (Seoul, Korea)|October 22, 2021
Metabolic Subtyping of Adrenal Tumors: Prospective Multi-Center Cohort Study in KoreaEu Jeong Ku, Chaelin Lee, Jaeyoon Shim, et al.
Diabetes & Metabolism Journal|March 7, 2022
A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes MellitusBo-Yeon Kim, Hyuk-Sang Kwon, Suk Kyeong Kim, et al.
Pageof 3